Market Research Logo

Global Molecular Diagnostics Market: Industry Analysis & Outlook (2018-2022)

Global Molecular Diagnostics Market: Industry Analysis & Outlook (2018-2022)

Diagnosis is the identification of the nature and cause of a certain phenomenon. It involves two different types of testing method: in vivo and in vitro diagnostics. In vitro diagnostics (IVD) are the medical tests which are intended to perform diagnoses from sample of body fluids in a controlled environment outside a living organism. In vitro diagnostic (IVD) tests are performed to conduct diagnoses from assays in a test tube, or in a controlled environment outside a living organism.

Molecular Diagnostics (MD) is a technology used in the process of in vitro diagnosis. Molecular diagnostics involves the measurement of DNA, RNA, proteins or metabolites in order to detect genotypes, mutations or biochemical changes in the body. Molecular diagnostics market is escalating beyond the identification of infections. It is becoming an essential part of disease management and therapy. The variety of technologies used in molecular diagnostics has transformed clinical laboratory medicine. The market is further expected to see a robust growth with increased research and development.

The global molecular diagnostics market is expected to see innovation driven growth. With recent outbreak of infectious diseases like Ebola and swine flu, they would require accurate diagnostics, which will instigate the growth of the molecular diagnostics technology in the future, thereby posing tremendous growth potential for the market.

The key factors driving growth of the MD market includes fast approvals for companion diagnostics reagents, increase in emergence of infectious disease, innovation and technical development, rising ageing population, and escalating global healthcare expenditure. However, there are certain factors hindering the growth of the market like high initial cost, obligation of skilled labor, and lack of proper healthcare infrastructure. The major trends featuring the market include progressing sample-to-answer molecular diagnostics market, growth in Point of Care Diagnostics (POCT), and emergence of Liquid Biopsy Solutions among others.

The report offers an in-depth analysis of the “Global Molecular Diagnostics Market”. It covers the regional and global aspect of the market. Competition is concentrated in the hands of few major companies, of which Roche Holding AG, Abbott Laboratories, Danaher Corporation and Hologic Inc., have been covered in the report.


1. Overview
1.1 Diagnostics
Table 1: IVD Market – Segments by Technology
1.2 Molecular Diagnostics
Table 2: Molecular Diagnostics – Traditional Process
Table 3: Molecular Diagnostics Breakdown
1.3 Purpose of Molecular Diagnostics
Table 4: Main Purposes of Molecular Diagnostics
2. Global In-Vitro Diagnostics (IVD) Market
2.1 Global IVD Market by Value
Table 5: Global IVD Market by Value (2013-2017)
2.2 Global IVD Market Forecast by Value
Table 6: Global IVD Market Forecast by Value (2018-2022)
2.3 Global IVD Market by Segment
Table 7: Global IVD Market by Segment (2017)
2.4 Global IVD Market by Technology
Table 8: Global IVD Market CAGR by Technology (2013-2017)
3. Global Molecular Diagnostics Market
3.1 Global Molecular Diagnostics Market by Value
Table 9: Global Molecular Diagnostics Market by Value (2013-2017)
3.2 Global Molecular Diagnostics Market Forecast by Value
Table 10: Global Molecular Diagnostics Market Forecast by Value (2018-2022)
3.3 Global Molecular Diagnostics Market by Application
Table 11: Global Molecular Diagnostics Market by Application (2017)
3.3.1 Global Infectious Disease Testing Market by Value
Table 12: Global Infectious Disease Testing Market by Value (2013-2017)
3.3.2 Global Infectious Disease Testing Market Forecast by Value
Table 13: Global Infectious Disease Testing Market Forecast by Value (2018-2022)
3.3.3 Global Infectious Disease Testing Market Value by Type
Table 14: Global Infectious Disease Testing Market Value by Type (2017)
3.3.4 Global CT/NG Market by Value & Volume
Table 15: Global CT/NG Market by Value & Volume (2013-2017)
3.3.5 Global CT/NG Market Forecast by Value & Volume
Table 16: Global CT/NG Market Forecast by Value & Volume (2018-2022)
3.3.6 Global HPV Testing Market by Value & Volume
Table 17: Global HPV Market by Value & Volume (2013-2017)
3.3.7 Global HPV Testing Market Forecast by Value & Volume
Table 18: Global HPV Market Forecast by Value & Volume (2018-2022)
3.3.8 Global Oncology Testing Market by Value
Table 19: Global Oncology Testing Market by Value (2013-2017)
3.3.9 Global Oncology Testing Market Forecast by Value
Table 20: Global Oncology Testing Market Forecast by Value (2018-2022)
3.3.10 Global Blood Screening Testing Market by Value
Table 21: Global Blood Screening Testing Market by Value (2013-2017)
3.3.11 Global Blood Screening Testing Market Forecast by Value
Table 22: Global Blood Screening Testing Market Forecast by Value (2018-2022)
3.3.12 Global Genetic Testing Market by Value
Table 23: Global Genetic Testing Market by Value (2013-2017)
3.3.13 Global Genetic Testing Market Forecast by Value
Table 24: Global Genetic Testing Market Forecast by Value (2018-2022)
3.4 Global Molecular Diagnostics Market by Technology
Table 25: Global Molecular Diagnostics Market by Technology (2017)
3.5 Global Molecular Diagnostics Market by Region
Table 26: Global Molecular Diagnostics Market by Region (2017)
4. Regional Market Analysis
4.1 North America
4.1.1 North America Molecular Diagnostics Market by Value
Table 27: North America Molecular Diagnostics Market by Value (2013-2017)
4.1.2 North America Molecular Diagnostics Market Forecast by Value
Table 28: North America Molecular Diagnostics Market Forecast by Value (2018-2022)
4.1.3 North America Molecular Diagnostics Market by Application
Table 29: North America Molecular Diagnostics Market by Application (2017)
4.1.4 North America Oncology Based Molecular Diagnostics Market by Value
Table 30: North America Oncology Based Molecular Diagnostics Market by Value (2013-2017)
4.1.5 North America Oncology Based Molecular Diagnostics Market Forecast by Value
Table 31: North America Oncology Based Molecular Diagnostics Market Forecast by Value (2018-2022)
4.1.6 North America Oncology Based Molecular Diagnostics Market by Product
Table 32: North America Oncology Based Molecular Diagnostics Market by Product (2017)
4.1.7 North America Oncology Based Reagents Market by Value
Table 33: North America Oncology Based Reagents Market by Value (2013-2017)
4.1.8 North America Oncology Based Reagents Market Forecast by Value
Table 34: North America Oncology Based Reagents Market Forecast by Value (2018-2022)
4.1.9 North America Oncology Based Instruments Market by Value
Table 35: North America Oncology Based Instruments Market by Value (2013-2017)
4.1.10 North America Oncology Based Instruments Market Forecast by Value
Table 36: North America Oncology Based Instruments Market Forecast by Value (2018-2022)
4.2 Western Europe
4.2.1 Western Europe Molecular Diagnostics Market by Value
Table 37: Western Europe Molecular Diagnostics Market by Value (2013-2017)
4.2.2 Western Europe Molecular Diagnostics Market Forecast by Value
Table 38: Western Europe Molecular Diagnostics Market Forecast by Value (2018-2022)
4.2.3 Western Europe Molecular Diagnostics Market by Application
Table 39: Western Europe Molecular Diagnostics Market by Application (2017)
4.3 Asia Pacific
4.3.1 Asia Pacific Molecular Diagnostics Market by Value
Table 40: Asia Pacific Molecular Diagnostics Market by Value (2013-2017)
4.3.2 Asia Pacific Molecular Diagnostics Market Forecast by Value
Table 41: Asia Pacific Molecular Diagnostics Market Forecast by Value (2018-2022)
4.3.3 Asia Pacific Molecular Diagnostics Market by Application
Table 42: Asia Pacific Molecular Diagnostics Market by Application (2017)
5. Market Dynamics
5.1 Growth Drivers
5.1.1 Fast Approvals for Companion Diagnostics (CD) Reagents
Table 43: The US approvals for CD Reagents
5.1.2 Rising Emergence of Infectious Diseases
Table 44: Growing Cases and Prevalence of STDs in the US (2010-2017)
5.1.3 Rise in Global Ageing Population
Table 45: Worldwide Ageing Population 60 Years or Older (2000-2030E)
5.1.4 Increasing Incidence of Cancer Cases
Table 46: Global Cancer Prevalence (2016-2021)
5.1.5 Rising Global Healthcare Expenditure
Table 47: Global Healthcare Expenditure Per Capita (2013-2017)
5.2 Key Trends and Developments
5.2.1 Progressing Sample-to-Answer Molecular Diagnostics Market
Table 48: Global Sample-to-Answer Molecular Diagnostics Market Value (2013-2017)
5.2.2 Growth in Point of Care Diagnostics (POCT)
Table 49: Global POCT Device Sales (2012-2017)
5.2.3 Booming Medical Devices Industry
Table 50: Global Medical Equipment/Devices Sales (2016/2022)
5.2.4 Innovation and Technical Developments
5.2.5 Emergence of Liquid Biopsy Solutions
5.2.6 Targeting Anti-Biotic Resistance
5.2.7 Decentralization of Diagnostic Testing
5.3 Challenges
5.3.1 High Initial Cost
5.3.2 Obligation of Skilled Labor
5.3.3 Urgent Need for Proper Infrastructure
6. Competitive Landscape
6.1 Global IVD Market
6.1.1 Global IVD Kit Market Share by Company
Table 51: Global IVD Kit Market Share by Company (2017)
6.2 Global Molecular Diagnostics Market
6.2.1 Global Molecular Diagnostics Market Share by Company
Table 52: Global Molecular Diagnostics Market Share by Company (2017)
6.2.2 Global Infectious Disease Testing Market Share by Company
Table 53: Global Infectious Disease Testing Market Share by Company (2017)
6.2.3 Global Blood Screening Testing Market Share by Company
Table 54: Global Blood Screening Testing Market Share by Company (2017)
6.2.4 Revenue and Market Cap Comparison
Table 55: Key Players - Revenue & Market Cap Comparison (2017)
7. Company Profiles
7.1 Roche Holding AG
7.1.1 Business Overview
Table 56: Roche Sales by Segments (2017)
7.1.2 Financial Overview
Table 57: Roche Sales and Net Income (2013-2017)
7.1.3 Business Strategies
Table 58: Roche Agreements (2017/2018)
Table 59: Roche Product Approvals (2018)
7.2 Abbott Laboratories
7.2.1 Business Overview
Table 60: Abbott Laboratories Sales by Segment (2017)
7.2.2 Financial Overview
Table 61: Abbott Laboratories Net Sales and Net Earnings (2013-2017)
7.2.3 Business Strategies
Table 62: Abbott Laboratories R&D Expenditure (2015-2017)
7.3 Danaher Corporation
7.3.1 Business Overview
Table 63: Danaher Corp. Revenue by Segments (2017)
7.3.2 Financial Overview
Table 64: Danaher Corp. Revenue and Net Earnings (2013-2017)
7.3.3 Business Strategies
Table 65: Danaher Corp. R&D Expenditure (2015-2017)
7.4 Hologic Inc.
7.4.1 Business Overview
Table 66: Hologic’s Revenue by Business Segments (2018)
7.4.2 Financial Overview
Table 67: Hologic Inc. Revenue and Net Income (2014-2018)
7.4.3 Business Strategies
Table 68: Hologic Inc. R&D Expenditure (2016-2018)
Table 69: Hologic Inc. Product Launches (2018)

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report